Nano X Imaging's U.S.-Based Subsidiary Signs Distribution Agreement With NuvioDx To Support Deployment Of Nanox.ARC Systems

Advances Nanox's ongoing U.S. commercialization and deployment efforts
 

PETACH TIKVA, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Nano X Imaging Ltd. (("Nanox", or the "Company", NASDAQ:NNOX), a leader in innovative medical imaging technology, today announced that its U.S.-based subsidiary, Nanox Impact Inc., has signed a distribution agreement with NuvioDx LLC ("NuvioDx"), an imaging solutions provider focused on expanding access to diagnostic imaging, to support the deployment of Nanox.ARC systems.

This agreement represents Nanox's growing distribution framework announced in 2026, following recent agreements, as the company continues to advance its channel partner strategy and build a diversified distribution network across the United States.

Under the terms of the agreement, NuvioDx will support the deployment of Nanox.ARC multi-source digital tomosynthesis systems across clinical sites in various states. The collaboration reflects Nanox's strategy of working with partners that bring regional market access and operational capabilities to support system deployment and sustained utilization.

The Nanox.ARC is an FDA-cleared, multisource digital tomosynthesis system that makes 3D imaging possible in more clinical settings, at a lower cost and reduced radiation dose compared to traditional CT.